Anna Gardarsdottir
Independent strategic advisor to CEOs and leadership teams on AI transformation.
Turning AI ambition into competitive advantage.
Anna Gardarsdottir's background combines advanced analytics, transformation leadership, and executive-level delivery inside a fast-scaling biopharma company. She has led complex cross-functional initiatives, shaped digital and AI strategy, built capabilities from the ground up, and worked at the precise intersection where most AI transformations either take root or quietly fail.
That background informs a particular kind of advisory work: rigorous, honest about trade-offs, and above all focused on strategic clarity — what to do, why, and in what order. The organisations that get clear on direction early, and build the capability to act on it, will be the ones that define their industries rather than respond to them.
2016–2018 MSc Mathematical Modelling and Computation, Technical University of Denmark (DTU). Master's project in collaboration with Trackman and Adidas: modelling football free-kick mechanics from strike conditions.
2017–2020 Part of the core engineering team at a company building precision ball-tracking technology used across professional sport. Developed tracking algorithms in Python and C++, working across radar signal processing, applied physics, and mathematical modelling — including applied machine learning for ball-flight prediction.
2020–2026 Joined a fast-scaling Icelandic biopharma company as a founding member of a process modelling innovation team within R&D. Led the adoption of an advanced hybrid process modelling platform across four scientist groups — a programme that required close engagement with the underlying science and a clear translation to business value at leadership level. Brought into a small task force reporting directly to the CEO to lead preparation for an FDA manufacturing inspection. Subsequently led a portfolio of strategic initiatives from the office of the CEO, including a learning and development platform and a major supply, demand, and financial planning software implementation.
2024–2025 Led the establishment of Fruman, a life science and biotechnology centre in Iceland — bringing together research facilities, an innovation accelerator, an education programme, and an investment fund.